| Returns | 1W : -4% , 1M : 6.7%,1Y : 29% |
| LT : |
Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : High |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| NARAYANA HRUDAYALAYA LTD | -4% | 6.7% | 29% |
| APOLLO HOSPITALS ENTERPRISE LTD | 1.5% | 11.3% | 53.8% |
| DR LAL PATHLABS LTD | 0.7% | 0.3% | 40.1% |
| FORTIS HEALTHCARE LTD | 2% | 11.9% | 7.4% |
| METROPOLIS HEALTHCARE LTD | -9.1% | 3.5% | 30.9% |
| ASTER DM HEALTHCARE LTD | -3.6% | -6.9% | -2.6% |
| THYROCARE TECHNOLOGIES LTD | -3.6% | -2.3% | 66.5% |
| SHALBY LTD | -4.6% | -4.9% | 7.5% |
| KOVAI MEDICAL CENTER & HOSPITAL LTD | -4.7% | 5% | 60.4% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
79.04
P/E Calculated based on EPS of 5.82
[ Mar2020 - Consolidated Results ] 8.3
P/B Calculated based on Book Value of 55.42
[ Mar2020 - Consolidated Results ] 3.43
P/S Calculated based on Revenues of 2743.94 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
2% 15% 37% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
